Monoclonal Antibody Diagnostic Reagent Global Market Report 2022: Extensive R&D Efforts to Develop Novel Therapies Driving Growth – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Monoclonal Antibody Diagnostic Reagent Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Tests and Application” report has been added to ResearchAndMarkets.com’s offering. The monoclonal antibody diagnostic reagent market is expected to grow from US$ 7,654.06 million in 2021 to US$ 18,507.20 million by 2028; it is expected to grow … [Read more…]

Nucleai Expands Scientific Advisory Board with Oncology Industry Luminary Dr. Julian Adams

TEL AVIV, Israel–(BUSINESS WIRE)–#aipowered–Nucleai, an AI-powered spatial biology leader, announced that Dr. Julian Adams has joined its scientific advisory board. Dr. Adams brings his more than 35 years of experience in oncology research and development to his role as an advisor to Nucleai, which is recognized as one of the top startups to watch in … [Read more…]

ImmunoTek Plasma Adds Second Location in Indiana

National Biotechnology Company Selects Indianapolis for New Location INDIANAPOLIS–(BUSINESS WIRE)–People in Indianapolis can soon help save lives by donating their blood plasma at a new donation center opening November 8, 2022. The new location is operated by ImmunoTek Plasma which has centers in 12 states and another Indiana location in Jeffersonville. Indianapolis is the 72nd … [Read more…]

Acadia Healthcare Acquires Four CTC Facilities in Georgia

Providing a critical healthcare service to communities surrounding Atlanta FRANKLIN, Tenn.–(BUSINESS WIRE)–Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced the recent acquisition of four comprehensive treatment centers (“CTC”) from Georgia-based Brand New Start Treatment Centers. The four centers are located in separate suburbs of the Atlanta metropolitan area, each within 40 miles of the city. … [Read more…]

Acadia Healthcare Set to Open Four New Comprehensive Treatment Centers

Facilities will offer outpatient care for adults 18 and older CUMMING, Ga. & LOGANVILLE, Ga. & DALLAS, Ga. & WOODSTOCK, Ga.–(BUSINESS WIRE)–Acadia Healthcare, a leading provider of behavioral healthcare services, is accepting new patients at its four new Comprehensive Treatment Centers (CTCs) in Georgia. Acadia recently acquired the four CTCs from Georgia-based Brand New Start … [Read more…]

Reimagine Care and The Center for Cancer & Blood Disorders Announce Partnership

Innovative, patient-centered approach to managing symptoms of cancer treatment will provide thousands of patients with a first of its kind, home-centered care model NASHVILLE, Tenn. & FORT WORTH, Texas–(BUSINESS WIRE)–Reimagine Care announced today that it has partnered with The Center for Cancer & Blood Disorders (CCBD), one of the country’s most respected cancer centers, to … [Read more…]

eClinicalWorks Cloud Reduces Costs by 50% for Hyndman Area Health Center

eClinicalWorks Cloud EHR enhances performance for Pennsylvania-based health center’s network access and capabilities WESTBOROUGH, Mass.–(BUSINESS WIRE)–eClinicalWorks®, the largest ambulatory cloud EHR, today announced that Hyndman Area Health Center — a holistic Pennsylvania-based health center providing family medicine, dental health, Behavioral Health and more — transitioned from client-hosted servers to the eClinicalWorks Cloud. By switching to … [Read more…]

PointClickCare Announces Real World Data Collaboration with Pfizer

Real world database fosters innovation for vulnerable populations MISSISSAUGA, Ontario–(BUSINESS WIRE)–PointClickCare Technologies, a leading healthcare technology platform enabling meaningful collaboration and access to real‐time insights, today announced a strategic collaboration with Pfizer Inc. to provide real world insights into the population at high risk of age-related disorders, which is aligned with PointClickCare’s mission to protect … [Read more…]

Pipeline Therapeutics to Present Multiple Posters at SFN 2022 Neuroscience Annual Meeting

SAN DIEGO–(BUSINESS WIRE)–Pipeline Therapeutics, a clinical-stage biopharmaceutical company pioneering precision neuroregeneration, announced today that it will present two posters at the SFN 2022 Neuroscience Annual Meeting, taking place November 12-16, 2022, in San Diego, CA. Poster Presentation Details: Title: “Discovery of remyelination therapeutics that overcome the effects of inflammatory macrophages on oligodendrocyte formation” Poster Number: … [Read more…]

Apnimed to Present at the Stifel Healthcare Conference

CAMBRIDGE, Mass.–(BUSINESS WIRE)–#OSA–Apnimed, a clinical-stage pharmaceutical company focused on developing oral pharmacologic therapies to address obstructive sleep apnea (OSA) and related disorders, including its lead candidate AD109, today announced that management will participate in the Stifel Healthcare Conference taking place November 15-16, 2022 in New York. Apnimed invites investors to view the live presentation and … [Read more…]